Scalable Copper Sulfide Formulations for Super‐Resolution Optoacoustic Brain Imaging in the Second Near‐Infrared Window
Small Methods · 2025-01 · 9 (1)
DOI: 10.1002/smtd.202400927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, online erschienen am 24.10.2024. Verfasst von Lin Tang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology and Toxicology and Institute for Biomedical Engineering, Faculty of Medicine, University of Zurich, Zurich, 8057, Switzerla…. Hauptthemen laut MEDLINE: Photoacoustic Techniques, Copper, Brain, Sulfides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, US National Institutes of Health, Swiss National Science Foundation.
Abstract (Originalsprache)
Optoacoustic imaging offers label‐free multi‐parametric characterization of cerebrovascular morphology and hemodynamics at depths and spatiotemporal resolution unattainable with optical microscopy. Effective imaging depth can greatly be enhanced by employing photons in the second near‐infrared (NIR‐II) window. However, diminished absorption by hemoglobin along with a lack of suitable contrast agents hinder an efficient application of the technique in this spectral range. Herein, copper sulfide (CuS) micro‐ and nano‐formulations for multi‐scale optoacoustic imaging in the NIR‐II window are introduced. Dynamic contrast enhancement induced by intravenously administered CuS nanoparticles facilitated visualization of blood perfusion in murine cerebrovascular networks. The individual calcium carbonate microparticles carrying CuS are further shown to generate sufficient responses to enable super‐resolution microvascular imaging and blood flow velocity mapping with localization optoacoustic tomography.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacology and Toxicology and Institute for Biomedical Engineering, Faculty of Medicine, University of Zurich, Zurich, 8057, Switzerland.
- Institute for Biomedical Engineering, Department of Information Technology and Electrical Engineering, ETH Zurich, Zurich, 8093, Switzerland.
- Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, 400076, India.
- Department of Medical Imaging, Shanxi Medical University, Taiyuan, 030001, China.
- Center for Research in Molecular Medicine and Chronic Diseases (CiMUS) and Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela, Santiago de Compostela, 15782, Spain.
- Experimental Biomedicine Centre (CEBEGA), University of Santiago de Compostela, Santiago de Compostela, 15782, Spain.
ORCID-Profile: Lin Tang, Daniel Razansky
Förderung
- NINDS NIH HHS
- US National Institutes of Health
- Swiss National Science Foundation
- Swiss Innovation Agency
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Tang, L., Nozdriukhin, D., Kalva, S. K., Zhou, Q., Özsoy, Ç., Lyu, S., Reiss, M., Vidal, A., Torres, A., Deán-Ben, X. L., & Razansky, D. (2025). Scalable Copper Sulfide Formulations for Super‐Resolution Optoacoustic Brain Imaging in the Second Near‐Infrared Window. Small Methods, 9(1). https://doi.org/10.1002/smtd.202400927
Vancouver
Tang L, Nozdriukhin D, Kalva SK, Zhou Q, Özsoy Ç, Lyu S, et al. Scalable Copper Sulfide Formulations for Super‐Resolution Optoacoustic Brain Imaging in the Second Near‐Infrared Window. Small Methods. 2025;9(1). doi:10.1002/smtd.202400927
BibTeX
@article{Tang2025,
author = {Tang, Lin and Nozdriukhin, Daniil and Kalva, Sandeep Kumar and Zhou, Quanyu and Özsoy, Çağla and Lyu, Shuxin and Reiss, Michael and Vidal, Anxo and Torres, Ana and Deán-Ben, Xosé Luís and Razansky, Daniel},
title = {Scalable Copper Sulfide Formulations for Super‐Resolution Optoacoustic Brain Imaging in the Second Near‐Infrared Window},
journal = {Small Methods},
year = {2025},
volume = {9},
number = {1},
doi = {10.1002/smtd.202400927}
}
EUVIMED